TY - JOUR
T1 - Essential to increase the use of generics in Europe to maintain comprehensive health care?
AU - Godman, Brian
AU - Bennie, Marion
AU - Baumgartel, Christoph
AU - Sović-Brkičić, Ljiljana
AU - Burkhardt, Thomas
AU - Fürst, Jurij
AU - Garuoliene, Kristina
AU - Gomes, Miguel
PY - 2012
Y1 - 2012
N2 - Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintain comprehensive health care in Europe given continued pressures. The alternative is insufficient funds for new innovative drugs and increasing drug volumes with ageing populations. To review the influence of measures and initiatives to increase the prescribing and dispensing of generics at low prices on ambulatory care prescribing efficiency. In view of this, provide guidance as authorities strive to introduce further reforms to meet their goals. A narrative review of published papers combined with case histories. The different supply- and demand-side measures have reduced generic prices to as low as 2% to 3% of pre-patent loss prices in some cases as well as appreciably enhanced their utilisation. As a result, prescribing efficiency has increased without compromising care. In some cases, the reforms have led to expenditure actually falling despite appreciably increased volumes. Increasing use of generics at low prices will help maintain the European ideals of comprehensive and equitable health care. However, countries will continually need to learn from each other.
AB - Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintain comprehensive health care in Europe given continued pressures. The alternative is insufficient funds for new innovative drugs and increasing drug volumes with ageing populations. To review the influence of measures and initiatives to increase the prescribing and dispensing of generics at low prices on ambulatory care prescribing efficiency. In view of this, provide guidance as authorities strive to introduce further reforms to meet their goals. A narrative review of published papers combined with case histories. The different supply- and demand-side measures have reduced generic prices to as low as 2% to 3% of pre-patent loss prices in some cases as well as appreciably enhanced their utilisation. As a result, prescribing efficiency has increased without compromising care. In some cases, the reforms have led to expenditure actually falling despite appreciably increased volumes. Increasing use of generics at low prices will help maintain the European ideals of comprehensive and equitable health care. However, countries will continually need to learn from each other.
KW - generics
KW - health care
KW - innovative drugs
UR - http://journals.edizioniseed.it/index.php/FE/article/view/312
M3 - Article
VL - 13
SP - 5
EP - 20
JO - Farmeconomia : Health Economics and Therapeutic Pathways
JF - Farmeconomia : Health Economics and Therapeutic Pathways
SN - 1721-6915
IS - 3S
ER -